跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-104
首页
药物
AT-104
AT-104
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS
EP 4551224 A4
申请人: ANTECIP BIOVENTURES II LLC
优先权: 2022
CN
EP
US
WO
26 件公开
EP 4777092 A1
申请人: ANTECIP BIOVENTURES II LLC
优先权: 2023
CN
EP
WO
3 件公开
Treatment of erectile dysfunction and other indications
US 9463158 B2
申请人: FOSSEL ERIC T
优先权: 2010
CN
US
WO
23 件公开
US 11684624 B2
申请人: STRATEGIC SCIENCE & TECH LLC
优先权: 2020
US
2 件公开
US 12138268 B2
申请人: STRATEGIC SCIENCE & TECH LLC
优先权: 2023
US
2 件公开
TOPICAL COMPOSITION
EP 3045171 A1
申请人: STRATEGIC SCIENCE & TECH LLC
优先权: 2009
EP
US
10 件公开
Arrangement for neutralisation or microorganisms
US 8475712 B2
申请人: HENRIKSSON PAR H
优先权: 2008
CN
EP
US
WO
5 件公开
BIOELECTRODE SHEET
EP 3597103 B1
申请人: FUKUDA DENSHI KK
优先权: 2017
CN
EP
US
WO
5 件公开
METHODS AND SYSTEMS FOR TREATMENT OF MIGRAINES AND OTHER INDICATIONS
US 2014010866 A1
申请人: FOSSEL ERIC T
优先权: 2010
CN
US
5 件公开
APPLICATION OF PEDF-DERIVED SHORT PEPTIDES IN THE TREATMENT OF OSTEOARTHRITIS
EP 3761958 A4
申请人: BRIM BIOTECHNOLOGY INC
优先权: 2018
CN
EP
US
WO
4 件公开
NEW USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A RESPIRATORY SYNCITIAL VIRUS PROTEIN AGAINST HMPV
EP 4082566 A4
申请人: UNIV PONTIFICIA CATOLICA CHILE
优先权: 2019
CN
EP
US
WO
4 件公开
METHOD OF SEPARATING SOLIDS FROM A SOLUTION DERIVED FROM PLASMA
EP 4532114 A4
申请人: CSL BEHRING AUSTRALIA PTY LTD
优先权: 2022
CN
EP
US
WO
4 件公开
Method and apparatus for hydrogenation and hyperpolarization of tracer molecules for magnetic resonance imaging
US 11493584 B2
申请人: UNIV FREIBURG ALBERT LUDWIGS
优先权: 2018
EP
US
WO
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈